The role of ECP in the management of GvHD

Learning Objectives

Learning objectives

Following this symposium, participants will be able to:

Recall the latest data and recommendations relating to ECP use in GvHD
Identify which patients will benefit from ECP
State factors that may warrant avoidance or deferral of ECP
State best-practice recommendations for conducting ECP, including treatment schedules, anticoagulation practice, and safety monitoring strategies
State when to use ECP in patients with GvHD
State when, why, and how to combine ECP with other therapies, such as immunosuppressive agents, for GvHD treatment

Registration form

Registration is free. Please complete the form and submit to register.

First Name *

Last Name *

Email *

Country

Speciality

I opt in to receive information about further educational opportunities from the GvHD Hub

I consent to receive emails from Scientific Education Support in relation to this session only *

I have read and agree to the terms & conditions *

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy